Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sylvain Meloche

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

ACS chemical biology

Cancers

Nature communications

Oncogene

Université de Montréal

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Montréal Jun 1o 2003

Canada

Professor :: Pharmacology and Physiology

Publications

Benoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, Scott Jarvis, Patrick Cléroux, Maud David, Pierre-Luc Tanguay, Laure Voisin, Clint James, Rico Lavoie, Yves Gareau, Joël Flynn-Robitaille, Thierry Lorca, Réjean Ruel, Anne Marinier, Sylvain Meloche
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen. ACS chemical biology (2023)
Guillaume Serwe, David Kachaner, Jessica Gagnon, Cédric Plutoni, Driss Lajoie, Eloïse Duramé, Malha Sahmi, Damien Garrido, Martin Lefrançois, Geneviève Arseneault, Marc K Saba-El-Leil, Sylvain Meloche, Gregory Emery, Marc Therrien
CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling. Nature communications 14 (1) (2023)
Benoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, Scott Jarvis, Patrick Cléroux, Maud David, Pierre-Luc Tanguay, Laure Voisin, Clint James, Rico Lavoie, Yves Gareau, Joël Flynn-Robitaille, Thierry Lorca, Réjean Ruel, Anne Marinier, Sylvain Meloche
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen. ACS chemical biology 18 (5) (2023)
Marjorie Lapouge, Sylvain Meloche
A renaissance for YES in cancer. Oncogene (2023)
Benoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, Scott Jarvis, Patrick Cléroux, Maud David, Pierre-Luc Tanguay, Laure Voisin, Clint James, Rico Lavoie, Yves Gareau, Joël Flynn-Robitaille, Thierry Lorca, Réjean Ruel, Anne Marinier, Sylvain Meloche
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen. ACS chemical biology 18 (5) (2023)
Benoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, Scott Jarvis, Patrick Cléroux, Maud David, Pierre-Luc Tanguay, Laure Voisin, Clint James, Rico Lavoie, Yves Gareau, Joël Flynn-Robitaille, Thierry Lorca, Réjean Ruel, Anne Marinier, Sylvain Meloche
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen. ACS chemical biology 18 (5) (2023)
Joaquim Javary, Eugénie Goupil, Mathilde Soulez, Evgeny Kanshin, Antoine Bouchard, Ole-Morten Seternes, Pierre Thibault, Jean-Claude Labbé, Sylvain Meloche
Phosphoproteomic analysis identifies supervillin as an ERK3 substrate regulating cytokinesis and cell ploidy. Journal of cellular physiology (2022)
Fadia Boudghene-Stambouli, Mathilde Soulez, Natalia Ronkina, Anneke Dörrie, Alexey Kotlyarov, Ole Morten Seternes, Matthias Gaestel, Sylvain Meloche
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Mathilde Soulez, Pierre-Luc Tanguay, Florence Dô, Junio Dort, Colin Crist, Alexey Kotlyarov, Matthias Gaestel, Mathieu Ferron, Nicolas A Dumont, Sylvain Meloche
ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation. Journal of cellular physiology 237 (4) (2022)
Thibault Houles, Geneviève Lavoie, Sami Nourreddine, Winnie Cheung, Éric Vaillancourt-Jean, Célia M Guérin, Mathieu Bouttier, Benoit Grondin, Sichun Lin, Marc K Saba-El-Leil, Stephane Angers, Sylvain Meloche, Philippe P Roux
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma. Nature communications 13 (1) (2022)
Fadia Boudghene-Stambouli, Mathilde Soulez, Natalia Ronkina, Anneke Dörrie, Alexey Kotlyarov, Ole Morten Seternes, Matthias Gaestel, Sylvain Meloche
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Jean-Philippe Guégan, Marjorie Lapouge, Laure Voisin, Marc K Saba-El-Leil, Pierre-Luc Tanguay, Kim Lévesque, Jérémy Brégeon, Anne-Marie Mes-Masson, Daniel Lamarre, Benjamin Haibe-Kains, Vincent Quoc-Huy Trinh, Geneviève Soucy, Marc Bilodeau, Sylvain Meloche
Signaling by the tyrosine kinase Yes promotes liver cancer development. Science signaling 15 (717) (2022)
Fadia Boudghene-Stambouli, Mathilde Soulez, Natalia Ronkina, Anneke Dörrie, Alexey Kotlyarov, Ole Morten Seternes, Matthias Gaestel, Sylvain Meloche
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Léo Aubert, Neethi Nandagopal, Zachary Steinhart, Geneviève Lavoie, Sami Nourreddine, Jacob Berman, Marc K Saba-El-Leil, David Papadopoli, Sichun Lin, Traver Hart, Graham MacLeod, Ivan Topisirovic, Louis Gaboury, Christoph J Fahrni, Daniel Schramek, Sylvain Meloche, Stephane Angers, Philippe P Roux
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nature communications 11 (1) (2020)
Charlotte Girondel, Kim Lévesque, Marie-Josée Langlois, Sarah Pasquin, Marc K Saba-El-Leil, Nathalie Rivard, Robert Friesel, Marc J Servant, Jean-François Gauchat, Sylvie Lesage, Sylvain Meloche
Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis. Oncogene 40 (2) (2020)

Sylvain Meloche.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sylvain Meloche